Market Place
Sourcing Support
Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit
22 Aug 2022 //
GLOBENEWSWIRE
Apabetalone`s Positive Impact on PAH Published in the ARCCD
17 Mar 2022 //
GLOBENEWSWIRE
Resverlogix expands Phase IIb apabetalone trial for Covid-19
18 Feb 2022 //
CLINICALTRIALSARENA
Resverlogix Commences Patient Enrollment and Dosing in a Phase 2b Trial
18 Jan 2022 //
GLOBENEWSWIRE
New Published Evidence of Apabetalone’s Beneficial Effects on COVID-19
03 Mar 2021 //
GLOBENEWSWIRE
Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure
12 Jan 2021 //
GLOBENEWSWIRE
A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone
26 Oct 2020 //
GLOBENEWSWIRE
Resverlogix Announces Publication of Key Apabetalone Study BETonMACE
30 Mar 2020 //
GLOBENEWSWIRE
Resverlogix Invites Collab for use of Apabetalone in Trials & Studies to Combat
23 Mar 2020 //
YAHOO
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.